The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...

The decision had been expected by April 1, but the agency now says it needs more information before moving forward.

The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1, but the agency ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Former Food and Drug Administration vaccine chief Dr. Peter Marks discussed his efforts to 'make nice' with Kennedy and ...